WebMar 25, 2024 · Arch Oncology General Information. Description. Developer of second-generation anti-CD47 antibodies designed to offer treatment for solid tumors. The … WebApr 13, 2024 · GlaxoSmithKline has agreed to acquire Sierra Oncology for $1.9 billion in a bet that an experimental drug the small biotech developed is on the cusp of becoming a valuable new treatment for a type of bone marrow cancer. GSK will pay $55 per share in cash for Sierra, a 39% premium to the company’s $39.52 closing price on Tuesday and a …
Sierra Oncology Company Profile: Acquisition & Investors …
WebApr 13, 2024 · Pharmaceutical giant GlaxoSmithKline PLC said Wednesday that it is buying biopharmaceutical company Sierra Oncology Inc. for $1.9 billion as it complements its … WebJul 1, 2024 · In June 2024, Sierra Oncology presented the complete data from the MOMENTUM phase III trial at the 2024 American Society of Clinical Oncology (ASCO) … bkl 263 mounts
GSK to Buy Sierra Oncology Amid Pressure to Boost Drug Pipeline
WebThis information is available in the PitchBook Platform. IPC advisors will continue to have an open architecture shelf and benefit from the self-managed independence they had at IGM. Izzy Englander's Millennium lost 0.15% over the month but is … WebApr 13, 2024 · LONDON GlaxoSmithKline plc (LSE/NYSE: GSK) and Sierra Oncology, Inc (Nasdaq: SRRA) today announced that the companies have entered into an agreement under which GSK will acquire Sierra Oncology, a California-based, late-stage biopharmaceutical company focused on targeted therapies for the treatment of rare forms of cancer, for $55 … WebIkena Oncology Inc is a targeted oncology company developing precision medicines tailored to biomarker-defined patient groups with specific unmet needs. Its lead targeted oncology … bk labs new mexico